Stock 1J5 HYPHENS PHARMA INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hyphens Pharma International Limited

Equities

1J5

SG1EE4000006

Pharmaceuticals

Market Closed - Singapore S.E.
Other stock markets
 04:13:30 2024-04-30 EDT 		5-day change 1st Jan Change
0.275 SGD +1.85% Intraday chart for Hyphens Pharma International Limited -.--% -3.51%
04-25 Hyphens Pharma International Limited Approves a Final Tax Exempt (One-Tier) Dividend for the Financial Year Ended 31 December 2023 CI
04-09 Hyphens Pharma’s Attributable Profit Narrows in 2023 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 63.09 94.64 92.63 103.4 88.12 84.9 - -
Enterprise Value (EV) 1 63.09 94.64 92.63 103.4 88.12 84.9 84.9 84.9
P/E ratio 9.68 x 15.4 x 13.2 x 9.15 x 10.3 x 7.65 x 7.08 x 7.05 x
Yield 4.76% 1.97% 2.23% 3.31% 15.6% 3.85% 4.05% 4.36%
Capitalization / Revenue 0.53 x 0.77 x 0.74 x 0.64 x 0.52 x 0.46 x 0.44 x 0.43 x
EV / Revenue 0.53 x 0.77 x 0.74 x 0.64 x 0.52 x 0.46 x 0.44 x 0.43 x
EV / EBITDA 6.23 x 10.2 x 8.78 x 6 x 6.46 x 5.27 x 5.2 x 5.7 x
EV / FCF 7.05 x 25.2 x -10.4 x 6.34 x 19.8 x 8.98 x 9.03 x 8.12 x
FCF Yield 14.2% 3.97% -9.59% 15.8% 5.04% 11.1% 11.1% 12.3%
Price to Book 1.44 x 2.01 x 1.7 x 1.5 x 1.4 x 1.17 x 1.05 x 0.98 x
Nbr of stocks (in thousands) 300,430 300,430 308,776 308,776 309,198 308,727 - -
Reference price 2 0.2100 0.3150 0.3000 0.3350 0.2850 0.2750 0.2750 0.2750
Announcement Date 20-02-26 21-02-25 22-02-23 23-02-28 24-02-27 - - -
1SGD in Million2SGD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 119.4 123.7 125.9 162.3 170.6 182.8 191.6 195.6
EBITDA 1 10.13 9.299 10.56 17.25 13.64 16.1 16.33 14.89
EBIT 1 8.125 7.218 8.351 14.53 10.84 12.9 13.7 14.8
Operating Margin 6.8% 5.84% 6.63% 8.95% 6.36% 7.06% 7.15% 7.57%
Earnings before Tax (EBT) 1 7.987 7.108 8.256 14.29 10.56 13.74 14.9 14.9
Net income 1 6.53 6.163 6.846 11.35 8.568 11.07 11.99 11.95
Net margin 5.47% 4.98% 5.44% 6.99% 5.02% 6.05% 6.26% 6.11%
EPS 2 0.0217 0.0205 0.0227 0.0366 0.0277 0.0360 0.0388 0.0390
Free Cash Flow 1 8.951 3.759 -8.879 16.32 4.445 9.45 9.4 10.46
FCF margin 7.49% 3.04% -7.05% 10.05% 2.61% 5.17% 4.91% 5.35%
FCF Conversion (EBITDA) 88.36% 40.42% - 94.6% 32.59% 58.71% 57.56% 70.25%
FCF Conversion (Net income) 137.08% 60.99% - 143.77% 51.88% 85.38% 78.39% 87.53%
Dividend per Share 2 0.0100 0.006200 0.006700 0.0111 0.0446 0.0106 0.0112 0.0120
Announcement Date 20-02-26 21-02-25 22-02-23 23-02-28 24-02-27 - - -
1SGD in Million2SGD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 8.95 3.76 -8.88 16.3 4.45 9.45 9.4 10.5
ROE (net income / shareholders' equity) 15.7% 13.5% 13.4% 18.3% 13% 16.2% 15.6% 14.4%
ROA (Net income/ Total Assets) 8.41% 7.37% 7.61% 10.6% 7.28% 9.3% 9.6% 8.7%
Assets 1 77.65 83.64 89.93 106.8 117.6 119 124.9 137.4
Book Value Per Share 2 0.1500 0.1600 0.1800 0.2200 0.2000 0.2400 0.2600 0.2800
Cash Flow per Share - - - - - - - -
Capex 1 0.5 0.37 0.84 1.32 1.2 2 2 3
Capex / Sales 0.42% 0.3% 0.66% 0.81% 0.7% 1.09% 1.04% 1.53%
Announcement Date 20-02-26 21-02-25 22-02-23 23-02-28 24-02-27 - - -
1SGD in Million2SGD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Hyphens Pharma International Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.275 SGD
Average target price
0.35 SGD
Spread / Average Target
+27.27%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
HYPHENS PHARMA INTERNATIONAL LIMITED Stock Hyphens Pharma International Limited
-3.51% 62.25M
MCKESSON CORPORATION Stock McKesson Corporation
+14.53% 69.79B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.2B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.55% 7.96B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-5.04% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+2.32% 4.69B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.32B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 3.99B
GALENICA AG Stock Galenica AG
-3.78% 3.81B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.42% 3.62B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 1J5 Stock
  4. Financials Hyphens Pharma International Limited